Abstract Title:
(-)-Epigallocatechin-3-gallate (EGCG) attenuates functional deficits and morphological alterations by diminishing apoptotic gene overexpression in skeletal muscles after sciatic nerve crush injury.
Abstract Source:Naunyn Schmiedebergs Arch Pharmacol。 2012年8月; 385(8):807-22。 Epub 2012年5月11日。PMID: 22573016
摘要作者:Waleed M Renno,May al-Maghrebi,Anwar al-Banaw
文章隶属关系: